Why is Ipca Labs falling/rising?

As of 14-Jul, Ipca Laboratories Ltd's stock price is currently at 1,457.25, reflecting an increase of 8.65 or 0.6%. The stock has shown a trend reversal by gaining after three consecutive days of decline. Despite this recent uptick, it underperformed its sector by 0.3% today and reached an intraday low of Rs 1419.6, which is a 2% decrease. Over the past week, the stock has slightly underperformed with a return of -0.02%, while it has performed better over the past month with a return of +6.47%. Notably, the company has reported positive results for the last four consecutive quarters, with a significant growth in profit after tax and a high return on capital employed, which may contribute to investor confidence.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has declined by 1.42% over the past week. While Ipca Laboratories has generated a return of 19.07% over the last year, significantly outperforming the market's return of 2.15%, it has seen a year-to-date decline of 13.85%, indicating some volatility. Additionally, the stock's liquidity appears adequate, but there has been a notable decrease in investor participation, with delivery volume falling by 44.5% against the five-day average. This decline in participation could signal caution among investors, despite the company's strong fundamentals and institutional backing.